Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01742572 · ClinicalTrials.gov registry record · NA

New DIETs: New Dietary Interventions Enhancing the Treatment for Weight Loss

A NA study, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
63
Enrollment target

NCT01742572: Completed NA study, sponsored by University of South Carolina.

NCT01742572 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01742572, a NA study, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target

Study Summary

Several studies have shown differences in health-related outcomes by dietary pattern. These patterns have included those participants following vegan (no meat, poultry, fish, dairy, or eggs), vegetarian (no meat, poultry, or fish), pesco- vegetarian (no meat or poultry), semi-vegetarian (red meat and poultry ≥ 1 time/month and \< 1 time/week), or omnivorous diets. These studies have shown that of these dietary patterns, vegans have the lowest BMIs, lowest prevalence of Type 2 diabetes, and lowest amount of weight gain over 5 years. In addition, vegetarians have significantly better metabolic risk factors as compared to non-vegetarians. While these initial observational studies have shown benefits to consuming more plant-based diets, there have been no randomized trials examining the differences in health outcomes among these dietary patterns. To begin exploring this research area, the investigators will conduct a pilot study which will randomize participants to one of the 5 dietary approaches. Participants (n=75) in the NEW DIETs Study will be recruited to follow their randomly assigned diet for 8 weeks and attend weekly sessions to learn about nutrition and cooking.

Interventions

  • BEHAVIORAL Diet

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2012-11
Est. Completion 2013-08
Phase NA
University of South Carolina

157 total trials

What the finished NCT01742572 record still lists

NCT01742572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Diet is the first listed.

NCT01742572 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01742572 about?

NCT01742572 is a clinical study titled "New DIETs: New Dietary Interventions Enhancing the Treatment for Weight Loss". Several studies have shown differences in health-related outcomes by dietary pattern. These patterns have included those participants following vegan (no meat, poultry, fish, dairy, or eggs), vegetarian (no meat, poultry, or fish), pesco- vegetarian (no meat or poultry), semi-vegetarian (red meat an...

What is the current status of trial NCT01742572?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2012-11. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01742572?

The interventions under investigation include: Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01742572?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01742572's enrollment target sits among peer trials

63 1157th of 2000 higher than 844 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03383575 · 63 participants · Phase 2

    Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

  • NCT04870944 · 63 participants · Phase 1

    CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • NCT05031897 · 63 participants · Phase 2

    Two Step Haplo With Radiation Conditioning

  • NCT05312671 · 63 participants · Phase 2

    Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01742572, the US trial registry maintained by the National Library of Medicine. NCT01742572 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.